Ku, L. C., Greenberg, R., Hornik, C. P., Morris, M., Anand, R., Lewandowski, A., … Smith, B. (2018). Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants. In PEDIATRICS (Vol. 142). https://doi.org/10.1542/peds.142.1_MeetingAbstract.183

Ku, Lawrence C., Rachel Greenberg, Christoph P. Hornik, Maurine Morris, Ravinder Anand, Andrew Lewandowski, Julie Debski, Kimberley Fisher, Matthew Laughon, and Brian Smith. “Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants.” In PEDIATRICS, Vol. 142, 2018. https://doi.org/10.1542/peds.142.1_MeetingAbstract.183.

Ku LC, Greenberg R, Hornik CP, Morris M, Anand R, Lewandowski A, et al. Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants. In: PEDIATRICS. 2018.

Ku, Lawrence C., et al. “Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants.” PEDIATRICS, vol. 142, 2018. Wos-lite, doi:10.1542/peds.142.1_MeetingAbstract.183.

Ku LC, Greenberg R, Hornik CP, Morris M, Anand R, Lewandowski A, Debski J, Fisher K, Laughon M, Smith B. Furosemide and Bumetanide Use and Clinical Outcomes in Extremely Low Birth Weight Infants. PEDIATRICS. 2018.